Teva To Continue Selling Generic Vicoprofen After Losing Vs. Abbott At Federal Circuit

Law360, New York (May 20, 2004, 12:00 AM EDT) -- Israeli generic drug maker Teva Pharmaceutical Industries plans to continue selling its version of Abbott Laboratories' pain medication vicoprofen, despite losing an appeal in a patent dispute.

Teva said the U.S. Court of Appeals for the Federal Circuit has vacated a September 2002 summary judgment which invalidated the patent protecting vicoprofen.

The district court had ruled that the U.S. patent was invalid as obvious, but the Federal Circuit disagreed with the lower court.

“Although the prior art appears to suggest combining an opioid, such as hydrocodone,...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.